Keynote review: intestinal Peyer's patch M cells and oral vaccine targeting.
about
Enhancing oral vaccine potency by targeting intestinal M cellsA review on the strategies for oral delivery of proteins and peptides and their clinical perspectivesTransport of chitosan-DNA nanoparticles in human intestinal M-cell model versus normal intestinal enterocytes.Peyer's Patches in the Terminal Ileum in Ulcerative Colitis: Magnifying Endoscopic Findings.Analysis of interactions of Salmonella type three secretion mutants with 3-D intestinal epithelial cellsComparative immunological evaluation of recombinant Salmonella Typhimurium strains expressing model antigens as live oral vaccines.A novel M cell-specific carbohydrate-targeted mucosal vaccine effectively induces antigen-specific immune responsesImplication of nanoparticles/microparticles in mucosal vaccine delivery.Intestinal permeability and its relevance for absorption and elimination.M-cells: origin, morphology and role in mucosal immunity and microbial pathogenesis.Development of non-antibiotic-resistant, chromosomally based, constitutive and inducible expression systems for aroA-attenuated Salmonella enterica Serovar TyphimuriumMucosal Lactobacillus vectored vaccines.Mucosal vaccines: novel advances in technology and delivery.Recent advances in mucosal delivery of vaccines: role of mucoadhesive/biodegradable polymeric carriers.Innovative bioinformatic approaches for developing peptide-based vaccines against hypervariable viruses.Bioadhesive delivery systems for mucosal vaccine delivery.Nanocompounds of iron and zinc: their potential in nutrition.Mucosal vaccines to prevent porcine reproductive and respiratory syndrome: a new perspective.Immunomodulation of Fungal β-Glucan in Host Defense Signaling by Dectin-1.Oral delivery of nanoparticle-based vaccines.Antibody responses in mice stimulated by various doses of the potato-derived major surface antigen of hepatitis B virus.Intestinal macrophages in Peyer's patches, sacculus rotundus and appendix of Angora rabbit.The third dimension: new developments in cell culture models for colorectal research.Expression of dengue-3 premembrane and envelope polyprotein in lettuce chloroplasts.Current state and challenges in developing oral vaccines.Translocation of enteropathogenic Escherichia coli across an in vitro M cell model is regulated by its type III secretion system.Induction of immune responses in mice and pigs by oral administration of classical swine fever virus E2 protein expressed in rice calli.Structural constraints for the binding of short peptides to claudin-4 revealed by surface plasmon resonance.Enhanced anticancer activity and oral bioavailability of ellagic acid through encapsulation in biodegradable polymeric nanoparticles.Preliminary studies on the development of IgA-loaded chitosan-dextran sulphate nanoparticles as a potential nasal delivery system for protein antigens.The role of L-arginine-nitric oxide pathway in bacterial translocation.A human intestinal M-cell-like model for investigating particle, antigen and microorganism translocation.Characterization of Vibrio cholerae neuraminidase as an immunomodulator for novel formulation of oral allergy immunotherapy.Role of Microbiota in Sexually Dimorphic Immunity.Coated hard capsules as the pH-dependent drug transport systems to ileo-colonic compartmentLipid coated mesoporous silica nanoparticles as an oral delivery system for targeting and treatment of intravacuolar Salmonella infections
P2860
Q21089613-417A1691-45BA-4F66-A0CE-FAEBAF3E9E3FQ26744008-4782FE0F-33C4-4DF7-8EAC-C33A6DD909B4Q33637851-382F46EF-3539-431E-9BD8-BE46F12E0B41Q33698933-B2DBC146-EFB6-497F-AE3E-E56FA8BE68BAQ33785722-2025DDC7-CE2C-458D-B6BC-5A1F1ADA9A29Q34421752-75101563-52FD-44AB-9F0A-3DE4F4333347Q36229159-D8A82F92-E76D-4E0A-A185-611EE26E00FDQ36837152-DE4C9D90-15EF-4C51-B661-3525FF2F99ABQ36985043-D39C5CEC-428B-4712-95B0-56C7F0FB8030Q37032884-E8CCB983-84C1-4DBF-852C-AB45FC249509Q37191421-809AD57D-FD52-4C24-B5CA-FD9AD919DB1AQ37521871-313B2CC9-0022-411B-8490-039B250A3833Q37559647-85313EAC-6116-4944-83E6-1727AA667C24Q37719553-6308F122-2020-4DF3-B134-40B892183514Q37748492-607B3641-5C79-4D1E-91F5-3EF16309AF5AQ37805519-EF7F1149-B6D2-4270-A4FE-5FDB1B169352Q37864102-72CBA873-9E4C-42FA-B0B0-FEC0D180A137Q38020309-E342F92E-64A4-4DD3-A6A5-AD053F99E038Q38134739-DD3967CC-34C2-45B5-B7C0-575BC4BE7AC9Q38243119-AEE219A6-A508-4A19-BA07-04F83ECB9206Q38480716-C7303A7E-DA8E-4A88-8C25-5925AD358AF3Q38647606-FCAA03A4-5BC3-4338-AFE2-9B24CF2FD7BBQ38773122-5C1376BB-9429-4E39-BAE1-C745F48E65ACQ39118535-45FEB9EC-23C7-422A-8632-0C787BEC431FQ39259629-DB8B9445-81B5-435D-BE09-58CE6E0EA5A3Q40171429-6864CEEA-E207-4554-A92C-E01F7875C64EQ40198011-E2B5C594-DF76-4C71-87E5-0A3E986232A2Q42152281-EBD0389F-D00D-4CF6-B7BA-696D405FAF4FQ42688385-BFC451FC-BD8F-447B-A5FA-CBE4E5C33D16Q44354579-673FA997-6029-4D53-B957-A1A8F0F370F4Q45146307-5B78E57E-D4ED-4D32-9FD4-87D7BA86A163Q48273711-463A6B1A-113D-4E57-A240-787826E8BAADQ52612978-9BCD1AE8-2478-4DFC-AFA3-6E5710AB69D5Q55313206-982997F0-94AE-4B04-B2C2-1DE9E2D79CA2Q57119804-B9A9E93F-DCC6-457C-8EB6-B9361071B80BQ57173201-6DBE4BB3-1EE4-44F1-88EA-92DC9FF87EA4
P2860
Keynote review: intestinal Peyer's patch M cells and oral vaccine targeting.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Keynote review: intestinal Peyer's patch M cells and oral vaccine targeting.
@ast
Keynote review: intestinal Peyer's patch M cells and oral vaccine targeting.
@en
type
label
Keynote review: intestinal Peyer's patch M cells and oral vaccine targeting.
@ast
Keynote review: intestinal Peyer's patch M cells and oral vaccine targeting.
@en
prefLabel
Keynote review: intestinal Peyer's patch M cells and oral vaccine targeting.
@ast
Keynote review: intestinal Peyer's patch M cells and oral vaccine targeting.
@en
P1433
P1476
Keynote review: intestinal Peyer's patch M cells and oral vaccine targeting
@en
P2093
Mark A Jepson
P304
P356
10.1016/S1359-6446(05)03536-1
P577
2005-09-01T00:00:00Z